Key terms
About XAIR
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XAIR news
Mar 20
9:09am ET
Beyond Air prices 9.64M shares at $1.66 in registered direct offering
Mar 14
5:33pm ET
Beyond Air’s Annual Meeting: Board Elections and Incentive Plan Expansion
Feb 16
4:36pm ET
Beyond Air’s Former CMO Becomes Paid Consultant
Feb 13
7:37am ET
Piper Sandler Remains a Buy on Beyond Air (XAIR)
Jan 07
5:46am ET
BTIG Sticks to Their Buy Rating for Beyond Air (XAIR)
Jan 02
9:55am ET
BTIG Remains a Buy on Beyond Air (XAIR)
Dec 31
5:28am ET
Beyond Air (XAIR) Receives a Buy from BTIG
Dec 27
7:35am ET
Beyond Cancer reports Phase 1 study of UNO clears first cohort
No recent press releases are available for XAIR
XAIR Financials
Key terms
Ad Feedback
XAIR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XAIR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
